The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome

Michael V Homer, Marcus A Rosencrantz, Rana F Shayya, R Jeffrey Chang, Michael V Homer, Marcus A Rosencrantz, Rana F Shayya, R Jeffrey Chang

Abstract

Background: The influence of estradiol (E2) on granulosa cell (GC) function has not been tested clinically in women with polycystic ovary syndrome (PCOS). The objective of this study is to determine if E2 influences GC responses to FSH in women with PCOS.

Methods: This is a two phase, single cohort study conducted over a 2-year period at a single academic center. Nine women with PCOS according to NIH criteria. In Phase 1, FSH stimulation of GC responses as measured by E2 and Inhibin B (Inh B) were assessed before and at 5 and 6 weeks after GnRH agonist administration. In Phase 2, the same protocol was employed with the addition of an aromatase inhibitor (letrozole, LET) administered daily beginning at week 4 for 2 weeks.

Results: In Phase 1, recovery of FSH, E2 and Inh B from ovarian suppression occurred at 5 and 6 weeks after GnRH agonist injection and preceded resumption of LH and androgen secretion. In Phase 2, hormone recovery after GnRH agonist was characterized by elevated FSH and suppressed E2 levels whereas recovery of LH and androgen levels were unchanged. In Phase 1, FSH stimulated E2 and Inh B responses were unaltered during recovery from ovarian suppression. In Phase 2, E2 and Inh B fold changes after FSH were significantly reduced at weeks 5 (p < 0.04) and 6 (p < 0.01), respectively.

Conclusion: In anovulatory women with PCOS, chronic, unopposed E2 secretion may contribute, at least in part, to enhanced ovarian responsiveness to FSH.

Trial registration: NCT02389088.

Keywords: Estradiol; FSH; Granulosa cell; Inhibin B; Polycystic ovary syndrome.

Figures

Fig. 1
Fig. 1
Serum hormone levels before and during recovery from GnRH agonist. Serum levels of FSH (IU/L), LH (IU/L) T (nmol/L), A (nmol/L), E2 (pmol/L) and Inh B (ng/L)
Fig. 2
Fig. 2
Serum hormone levels before and during recovery from GnRH agonist together with LET. Serum levels of FSH (IU/L), LH (IU/L) T (nmol/L), A (nmol/L), E2 (pmol/L) and Inh B (ng/L)

References

    1. Coffler MS, Patel K, Dahan MH, Malcom PJ, Kawashima T, Deutsch R, et al. Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:1742–7. doi: 10.1210/jc.2002-021280.
    1. Erickson GF, Magoffin DA, Cragun JR, Chang RJ. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab. 1990;70:894–902. doi: 10.1210/jcem-70-4-894.
    1. Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81:302–9.
    1. Adashi EY, Hsueh AJ. Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells. J Biol Chem. 1982;257:6077–83.
    1. Burghardt RC, Anderson E. Hormonal modulation of gap junctions in rat ovarian follicles. Cell Tissue Res. 1981;214:181–93. doi: 10.1007/BF00235155.
    1. Jonassen JA, Bose K, Richards JS. Enhancement and desensitization of hormone-responsive adenylate cyclase in granulosa cells of preantral and antral ovarian follicles: effects of estradiol and follicle-stimulating hormone. Endocrinology. 1982;111:74–9. doi: 10.1210/endo-111-1-74.
    1. Merk FB, Botticelli CR, Albright JT. An intercellular response to estrogen by granulosa cells in the rat ovary; an electron microscope study. Endocrinology. 1972;90:992–1007. doi: 10.1210/endo-90-4-992.
    1. Daniel SA, Armstrong DT. Involvement of estrogens in the regulation of granulosa cell aromatase activity. Can J Physiol Pharmacol. 1983;61:507–11. doi: 10.1139/y83-077.
    1. Richards JS, Ireland JJ, Rao MC, Bernath GA, Midgley AR, Reichert LE. Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone. Endocrinology. 1976;99:1562–70. doi: 10.1210/endo-99-6-1562.
    1. Richards JS, Jonassen JA, Rolfes AI, Kersey K, Reichert LE. Adenosine 3’,5’-monophosphate, luteinizing hormone receptor, and progesterone during granulosa cell differentiation: effects of estradiol and follicle-stimulating hormone. Endocrinology. 1979;104:765–73. doi: 10.1210/endo-104-3-765.
    1. Dokras A, Habana A, Giraldo J, Jones E. Secretion of inhibin B during ovarian stimulation is decreased in infertile women with endometriosis. Fertil Steril. 2000;74:35–40. doi: 10.1016/S0015-0282(00)00568-9.
    1. Rosencrantz MA, Wachs DS, Coffler MS, Malcom PJ, Donohue M, Chang RJ. Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women. Hum Reprod Oxf Engl. 2010;25:198–203. doi: 10.1093/humrep/dep373.
    1. de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, et al. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. J Clin Endocrinol Metab. 1989;68:1111–7. doi: 10.1210/jcem-68-6-1111.
    1. Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ, et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:5321–5327. doi: 10.1210/jc.2004-0643.
    1. Almahbobi G, Anderiesz C, Hutchinson P, McFarlane JR, Wood C, Trounson AO. Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol (Oxf) 1996;44:571–580. doi: 10.1046/j.1365-2265.1996.724545.x.
    1. Fitzpatrick SL, Richards JS. Regulation of cytochrome P450 aromatase messenger ribonucleic acid and activity by steroids and gonadotropins in rat granulosa cells. Endocrinology. 1991;129:1452–62. doi: 10.1210/endo-129-3-1452.
    1. Goldenberg RL, Vaitukaitis JL, Ross GT. Estrogen and follicle stimulation hormone interactions on follicle growth in rats. Endocrinology. 1972;90:1492–8. doi: 10.1210/endo-90-6-1492.
    1. Knecht M, Darbon JM, Ranta T, Baukal AJ, Catt KJ. Estrogens enhance the adenosine 3’,5’-monophosphate-mediated induction of follicle-stimulating hormone and luteinizing hormone receptors in rat granulosa cells. Endocrinology. 1984;115:41–9. doi: 10.1210/endo-115-1-41.
    1. Knecht M, Tsai-Morris CH, Catt KJ. Estrogen dependence of luteinizing hormone receptor expression in cultured rat granulosa cells. Inhibition of granulosa cell development by the antiestrogens tamoxifen and keoxifene. Endocrinology. 1985;116:1771–7. doi: 10.1210/endo-116-5-1771.
    1. Zhuang LZ, Adashi EY, Hsuch AJ. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology. 1982;110:2219–21. doi: 10.1210/endo-110-6-2219.
    1. Couse JF, Yates MM, Deroo BJ, Korach KS. Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology. 2005;146:3247–62. doi: 10.1210/en.2005-0213.
    1. Chang X, Wu J. Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 2013;29:196–200.
    1. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 1976;57:1320–9. doi: 10.1172/JCI108400.
    1. DeFazio J, Meldrum DR, Lu JK, Vale WW, Rivier JE, Judd HL, et al. Acute ovarian responses to a long-acting agonist of gonadotropin-releasing hormone in ovulatory women and women with polycystic ovarian disease. Fertil Steril. 1985;44:453–9. doi: 10.1016/S0015-0282(16)48911-9.
    1. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124:601–609. doi: 10.1530/rep.0.1240601.
    1. Hayes E, Kushnir V, Ma X, Biswas A, Prizant H, Gleicher N, et al. Intra-cellular mechanism of anti-Müllerian hormone (AMH) in regulation of follicular development. Mol Cell Endocrinol. 2016;433:56–65. doi: 10.1016/j.mce.2016.05.019.
    1. Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril. 2010;93:192–8. doi: 10.1016/j.fertnstert.2008.09.064.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner